Abstract
This first chapter is devoted to the definition of the environmental problem, in size and depth, resulting from the consumption of psychiatric pharmaceuticals. Classification of pharmaceuticals and overall figures concerning production and consumption are presented, substantiated by national, regional and worldwide examples. The lifecycle of pharmaceuticals is addressed in order to justify the environmental impact expected from the generalized usage of medicines. A global explanation and discussion is presented to clarify the processes through which those molecules reach and accumulate in environment. Particular attention is paid to main groups of psychiatric drugs and their relevant physical-chemical characteristics in terms of environmental impact are listed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alder AC, Bruchet A, Carballa M, Clara M, Joss A, Löffler D, McArdell CS, Miksch K, Omil F, Tuhkanen T, Ternes TA (2006) Consumption and occurrence. In: Ternes TA, Joss A (eds) Human pharmaceuticals, hormones and fragrances. The challenge of micropollutants in urban water management. IWA Publishing, London, pp 15–45
Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB (2008) A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States—I) groundwater. Sci Total Environ 402(2–3):192–200
Calisto V, Esteves VI (2009) Psychiatric pharmaceuticals in the environment. Chemosphere 77(10):1257–1274
Ciccone CD (2007) Pharmacology in rehabilitation. Contemporary perspectives in rehabilitation. F. A. Davis Company, USA
Courtheyn D, Le Bizec B, Brambilla G, De Brabander HF, Cobbaert E, Van de Wiele M, Vercammen J, De Wasch K (2002) Recent developments in the use and abuse of growth promoters. Anal Chim Acta 473(1–2):71–82
EEA (2010) Pharmaceuticals in the environment. In: Results of EEA workshop. EEA technical report No 1/2010. Copenhagen
Esplugas S, Bila DM, Krause LGT, Dezotti M (2007) Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J Hazard Mater 149(3):631–642
Eurobarometer (2010) Mental health part 1: report directorate general health and consumers survey co-ordinated by directorate general, communication
Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76(2):122–159
Heidler J, Halden RU (2008) Meta-analysis of mass balances examining chemical fate during wastewater treatment. Environ Sci Technol 42(17):6324–6332
Houtman CJ, Kroesbergen J, Lekkerkerker-Teunissen K, van der Hoek JP (2014) Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data. Sci Total Environ 496:54–62
INCB (2009) International narcotics control board, psychotropic substances—statistics for 2007. United Nations, New York
INFARMED—Estatística do Medicamento http://www.infarmed.pt/portal/page/portal/INFARMED/MONITORIZACAO_DO_MERCADO/OBSERVATORIO/ESTATISTICA_DO_MEDICAMENTO. Accessed Jan 2015
Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 107(6):2319–2364
Kümmerer K (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—a review. Chemosphere 45(6–7):957–969
Leonard BE (2010) Classification of psychoactive drugs. Encyclopedia of psychopharmacology. Springer, Heidelberg
Loos R, Wollgast J, Huber T, Hanke G (2007) Polar herbicides, pharmaceutical products, perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and nonylphenol and its carboxylates and ethoxylates in surface and tap waters around Lake Maggiore in Northern Italy. Anal Bioanal Chem 387(4):1469–1478
Matamoros V, Bayona JM (2006) Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ Sci Technol 40(18):5811–5816
Moldovan Z (2006) Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 64(11):1808–1817
Monteiro SC, Boxall ABA (2010) Occurrence and fate of human pharmaceuticals in the environment. In: Reviews of environmental contamination and toxicology, vol 202. Reviews of environmental contamination and toxicology. Springer, New York, pp 53–154
Moreno-González R, Rodríguez-Mozaz S, Gros M, Pérez-Cánovas E, Barceló D, León VM (2014) Input of pharmaceuticals through coastal surface watercourses into a Mediterranean lagoon (Mar Menor, SE Spain): sources and seasonal variations. Sci Total Environ 490:59–72
Nandi A, Beard J, Galea S (2009) Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic review. BMC Psychiatry 9(1):31
OECD (2014) Health at a glance: Europe 2014
Pedrouzo M, Reverté S, Borrull F, Pocurull E, Marcé RM (2007) Pharmaceutical determination in surface and wastewaters using high-performance liquid chromatography-(electrospray)-mass spectrometry. J Sep Sci 30(3):297–303
Sacher F, Lange FT, Brauch H-J, Blankenhorn I (2001) Pharmaceuticals in groundwaters: analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J Chromatogr A 938(1–2):199–210
Sadezky A, Lӧffler D, Schlüsener M, Roig B, Ternes T (2010) Real situation: occurence of the main investigated PPs in water bodies. In: Roig B (ed) Pharmaceuticals in the environment: current knowledge and need assessment to reduce presence and impact. IWA Publishing, London
Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175(1–3):45–95
Sethi S (2008) Textbook of psychiatry. Elsevier, New Delhi
Silva LJG, Lino CM, Meisel LM, Pena A (2012) Selective serotonin re-uptake inhibitors (SSRIs) in the aquatic environment: an ecopharmacovigilance approach. Sci Total Environ 437:185–195
SRC—Interactive PhysProp Database (2011) http://www.srcinc.com/what-we-do/product.aspx?id=133
Verlicchi P, Al Aukidy M, Zambello E (2012) Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review. Sci Total Environ 429:123–155
Wen Z-H, Chen L, Meng X-Z, Duan Y-P, Zhang Z-S, Zeng EY (2014) Occurrence and human health risk of wastewater–derived pharmaceuticals in a drinking water source for Shanghai, East China. Sci Total Environ 490:987–993
WHO (2011) Pharmaceuticals in drinking-water World Health Organization, Geneva
Wu C, Spongberg AL, Witter JD, Fang M, Czajkowski KP (2010) Uptake of pharmaceutical and personal care products by soybean plants from soils applied with biosolids and irrigated with contaminated water. Environ Sci Technol 44(16):6157–6161
Yuan S, Jiang X, Xia X, Zhang H, Zheng S (2013) Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 90(10):2520–2525
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 The Author(s)
About this chapter
Cite this chapter
Silva, B., Costa, F., Neves, I.C., Tavares, T. (2015). Introduction. In: Psychiatric Pharmaceuticals as Emerging Contaminants in Wastewater. SpringerBriefs in Molecular Science(). Springer, Cham. https://doi.org/10.1007/978-3-319-20493-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20493-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20492-5
Online ISBN: 978-3-319-20493-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)